- Home
- Life Sciences
- Coronary Stents
Coronary Stents Market Research Report – Segmented By Region (North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America) – Analysis on Size, Share, Trends, COVID-19 Impact, Competitive Analysis, Growth Opportunities and Key Insights from 2019 to 2030.
-
Published date -30th Jan 2024
-
Formats -PDF, CSV
-
Region -Global
Coronary Stents Market Analysis
1. What is the Market Size & CAGR of Coronary Stents market in 2021?
The global coronary stents market had a market size of USD 7.1 billion in 2021, with a Compound Annual Growth Rate (CAGR) of 5.2%.
2. COVID-19 Impact on the Coronary Stents Market
The COVID-19 pandemic had a significant impact on the coronary stents market, with a temporary decline in procedures and demand due to healthcare systems focusing on managing the pandemic. However, as the situation stabilizes, the market is expected to recover.
3. Coronary Stents Dynamics
The coronary stents market is driven by factors such as the prevalence of cardiovascular diseases, technological advancements in stent design, and increasing awareness about minimally invasive procedures. However, challenges like regulatory hurdles and high costs hinder market growth.
4. Segments and Related Analysis
Types of Coronary Stents
- Bare Metal Stents
- Drug-Eluting Stents
- Bioabsorbable Stents
Drug-eluting stents are the dominant segment due to their ability to reduce restenosis rates compared to bare metal stents.
5. By Region Analysis
Regional Market Share
North America leads the coronary stents market, followed by Europe and Asia Pacific. The Middle East and Africa region show potential for growth.
6. Key Market Players and Competitive Landscape
Major Players
- Abbott Laboratories
- Boston Scientific Corporation
- Medtronic Plc
- Biotronik
- Terumo Corporation
These companies compete based on product quality, pricing, and technology advancements.
7. Recent happenings in the Coronary Stents Market
In recent news, Abbott launched a new bioresorbable stent technology, revolutionizing the stent market with its innovative design. Boston Scientific announced a partnership with a research institute to develop next-generation drug-eluting stents.